Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
about
Identification of a dehydrogenase acting on D-2-hydroxyglutarateFructosamine 3-kinase-related protein and deglycation in human erythrocytesFructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytesA conserved phosphatase destroys toxic glycolytic side products in mammals and yeast.Magnesium-dependent phosphatase-1 is a protein-fructosamine-6-phosphatase potentially involved in glycation repairGlycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products.Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.The sour side of neurodegenerative disorders: the effects of protein glycation.Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli.Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysisFructoselysine 3-epimerase, an enzyme involved in the metabolism of the unusual Amadori compound psicoselysine in Escherichia coliIdentification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.Low red blood cell levels of deglycating enzymes in colorectal cancer patients.Purification and identification of activating enzymes of CS-0777, a selective sphingosine 1-phosphate receptor 1 modulator, in erythrocytesDiabetes control and complications: the role of glycated haemoglobin, 25 years on.Crystal structure of the deglycating enzyme fructosamine oxidase (amadoriase II)Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.Medical bioremediation of age-related diseases.Enzymatic repair of Amadori products.Glycation research in amino acids: a place to call home.Protein damage in diabetes and uremia--identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Dicarbonyl proteome and genome damage in metabolic and vascular disease.Impaired proteostasis: role in the pathogenesis of diabetes mellitus.Baking, ageing, diabetes: a short history of the Maillard reaction.The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.Advancing the development of glycated protein biosensing technology: next-generation sensing molecules.Increased protein glycation in fructosamine 3-kinase-deficient mice.The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging.Mass spectrometric determination of early and advanced glycation in biology.Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress.Functional analysis of fructosyl-amino acid oxidases of Aspergillus oryzae.Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1).Bacterial enzymes that can deglycate glucose- and fructose-modified lysine.Identification of protein-ribulosamine-5-phosphatase as human low-molecular-mass protein tyrosine phosphatase-A.
P2860
Q24328897-F6CCFC9A-AB45-4C6D-AB57-A5C8E811395BQ24528116-D2F6B648-4B71-4FCC-B6F6-C8E3BCF944FAQ24534263-B9604B74-9A38-4FBE-B6D7-FD614847AEE0Q27934919-8375FC43-A60C-44AC-95F3-039F9DE52645Q28569023-217A7B9D-DDFF-4017-B1BD-06E24FF0D5B8Q30376144-36F8B2F9-BACF-4E08-BCF8-BDC63456FDFEQ30378957-A2557FF1-48A6-4476-82F4-D819C1CA042CQ30386079-8D9BD3DE-EDB3-4012-8E71-3F03F60D9DD8Q30708333-9F79FDFC-A9D0-4E92-8C9B-E7E3447C820AQ34023341-EA651AD6-B8F3-4918-B82E-FA65F428B4AAQ34279306-D358BD83-A46D-4D98-A132-2337C611126BQ34315577-05572521-38AD-4116-8361-A1799431D603Q34343609-67071EC0-E712-4BA8-A9F2-9CFBCC219E79Q34393053-465AE564-DD2B-4EAC-9ADC-E16BDE979991Q34436032-5469BDCE-1459-4BDE-A16A-71BB70F606F2Q34490546-7443F520-D899-437D-A9E1-E81BDD5BE443Q34497444-0320F973-CA13-43CA-8568-EF0F785D470FQ35107430-19412B12-13A9-48CC-B7C6-99FC55A0413BQ35812833-B639C02B-3990-4AB7-9C23-F33F7C6AD39FQ36914458-F87D7B58-F0D2-4CF2-A50C-9FB41A3D807CQ37072018-85C2DBF5-B19E-4D53-86FA-55659515B0BCQ37112969-218AAC7E-4154-4555-B09C-E03EA81378C6Q37172423-B5FED471-65CD-42EA-AE08-344868FB1817Q37802272-049BF769-D38F-43CC-B203-8C437D6DADEDQ37803550-8D4CE318-FAA2-44BC-9D4C-0DD05662969FQ37812619-C3822FE9-EC62-4C79-9FFD-0DB84DE5088DQ38096444-6B32A14F-1993-48F3-B24A-4035EE48309EQ38197339-CA443419-BB70-4ECA-984B-15F39ECA3E35Q38210860-519A08C8-2FA3-4EB9-ABF8-6B164539B511Q38232036-F913323C-AE16-43F3-8A3F-1D86FEB7D353Q38241689-00424075-CE9D-41DE-BFAA-2A28D3CB6546Q38334761-83D6EE56-CA82-454A-9E53-A9DF3B7F2154Q38663198-2BF152D0-9371-4CBF-8B21-9440A764C7A5Q38663293-783639DA-6D59-4403-9980-597A90221B46Q38839770-6BAFE618-4911-4B25-8B5E-AD68E6C80CC3Q40047034-918FF262-FA7B-4ED1-ACB3-0C9F1A7F5F1AQ40172628-5BC87C30-CCA7-416E-B5F3-84C9C2EE07A3Q40194230-A77786D4-4DC2-4074-BB78-F83644121B5DQ40678299-F37871F9-4E25-4B04-B3D3-1C60972B63EBQ41807890-08DD872B-6748-4040-A6DC-C0473AD2D241
P2860
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@ast
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en-gb
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@nl
type
label
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@ast
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en-gb
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@nl
prefLabel
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@ast
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en-gb
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@nl
P2093
P921
P3181
P1433
P1476
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
@en
P2093
E Van Schaftingen
G Delpierre
V Stroobant
P304
P3181
P356
10.2337/DIABETES.49.10.1627
P407
P577
2000-10-01T00:00:00Z